Can Frankincense Help Defeat Hepatitis C?
Oct 15, 2012
1 Comment
The compelling rationale behind using frankincense to fight Hepatitis C has yet to be verified.
Continue reading »General Hepatitis C News/Updates
Three Reasons to Snack on Pumpkin Seeds for Those with Advanced Hepatitis
When living with cirrhosis, be aware of the pros and cons of snacking on pumpkin seeds.
Continue reading »Urgent Reason for Hep C Patients to Get Lean!
Sep 24, 2012
1 Comment
Hepatitis C paired with a BMI over 30 dramatically increases the risk of primary liver cancer development.
Continue reading »Gilead’s Sofosbuvir Gets High Marks for HIV/HCV Co-Infection
Although those co-infected with Hepatitis C and HIV generally have a poorer prognosis and are harder to treat than those with mono-infection, the experimental Hepatitis C drug, sofosbuvir, appears to improve the outlook of this common dual infection.
Continue reading »Are There Shades of Grey in Hepatitis C Treatment Success?
Sep 11, 2012
16 Comments
New research suggests that even previous non-responders to Hepatitis C treatment could benefit from the medications they once took.
Continue reading »Hepatitis C Biopump Trials Get Green Light
In Israel, Medgenics has been approved to deliver a naturally-produced interferon alpha for Hepatitis C via a biopump in trials for treatment naïve patients and those who have previously relapsed.
Continue reading »Concerns Halt Idenix Hep C Drug
Because of its likeness to Bristol-Myers' Hepatitis C drug that was associated with heart problems, Idenix's IDX19368 has been placed on a clinical hold by the FDA.
Continue reading »New Study: Early Hepatitis C Progression Detection
A National Institutes of Health study predicts who will develop advanced fibrosis and cirrhosis rapidly from Hepatitis C infection.
Continue reading »Hep C Trial with Sovaprevir Has 85% Success Rate
Aug 20, 2012
15 Comments
In a mid-stage trial, Achillion's experimental drug, sovaprevir, demonstrated an excellent efficacy rate and safety profile.
Continue reading »Can GKT137831 – a NOX Inhibitor – Stop Liver Fibrosis?
A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.
Continue reading »
